Pneumonia

• 1. Introduction

  ›

  Pneumonia has been called "the old man's friend". The phrase belongs to Sir William Osler, often known as the father of modern medicine, who also gave it a grimmer name: "the captain of the men of death". He used that title in 1918, when this lung condition had overtaken tuberculosis as a leading killer. Two names, both from one physician, capture the strange double nature of the disease. It can end a long period of suffering quickly and almost painlessly for those already close to death. It can also strike down the very young, the very old, and the chronically ill with frightening speed.

  Each year pneumonia reaches roughly 450 million people, about 7 percent of the world's population. It results in around 4 million deaths. Yet most listeners have never heard it described as anything more than a bad infection of the lungs. What actually happens inside the small air sacs called alveoli when they flood with fluid? Why does the same illness behave so differently in a newborn, a hospital patient on a ventilator, and a farm worker exposed to birds? And how did a disease that Hippocrates called one "named by the ancients" become survivable for the first time only in the last century? Those are the questions this documentary follows into the lungs and back out again.

• 2. Inside The Alveoli

  ›

  Half of all healthy people breathe small amounts of throat bacteria into their lungs while they sleep. Most of the time nothing happens. The upper airway carries a normal population of microbes that protect their host by competing with invaders for nutrients. In the lower airways, the reflexes of the glottis, along with complement proteins and immunoglobulins, stand guard. Pneumonia begins when those defenses fail and contaminated secretions slip past them into the lower airways.

  Bacteria that reach the alveoli set off a small war between cells. Defensive white blood cells, the macrophages and neutrophils, try to inactivate the invaders. The neutrophils release cytokines that switch on the wider immune system, which produces the fever, chills, and fatigue so common in bacterial cases. As neutrophils, bacteria, and fluid from nearby blood vessels fill the air sacs, the lung region solidifies. This is the consolidation that shows up later as a white patch on a chest X-ray.

  Viruses take different roads into the lung. Respiratory syncytial virus usually arrives when someone touches a contaminated object and then their own eyes or nose. Others ride in airborne droplets breathed through the nose or mouth. Once inside, viruses invade the cells lining the airways and air sacs, and a few, such as measles and herpes simplex, travel through the blood. The immune response that follows can damage the lung further. Many viruses harm other organs at the same time, and they leave the body open to a second, bacterial attack, so the two kinds of pneumonia can run together at once.

• 3. A Census Of Culprits

  ›

  More than 100 strains of infectious agents have been identified as causes, yet only a handful drive most cases. Bacteria lead community-acquired pneumonia, with Streptococcus pneumoniae isolated in nearly half of cases. Behind it come Haemophilus influenzae in about 20 percent, Chlamydophila pneumoniae in 13 percent, and Mycoplasma pneumoniae in around 3 percent. Drug-resistant versions are spreading, including drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus.

  A person's habits and exposures point toward specific organisms. Alcoholism is linked to Streptococcus pneumoniae, anaerobic organisms, and Mycobacterium tuberculosis. Contact with birds raises the chance of Chlamydia psittaci, while farm animals are associated with Coxiella burnetti, and cystic fibrosis with Pseudomonas aeruginosa and Staphylococcus aureus. Smoking eases the way for several bacteria at once, and Streptococcus pneumoniae appears more often in winter.

  Viruses account for about a third of adult cases and roughly 15 percent in children, and they include rhinoviruses, influenza, and respiratory syncytial virus. A surveillance study across five hospitals in Chicago and Nashville, running from January 2010 through June 2012, examined 2,259 patients with X-ray evidence of pneumonia. Most, 62 percent, had no detectable pathogen at all. Viruses turned up more often than bacteria, with human rhinovirus the single most common, found in 9 percent of patients. Fungal cases are uncommon and tend to strike weakened immune systems, with histoplasmosis most frequent in the Mississippi River basin. Parasites round out the list, most often among the immunodeficient and in travelers returning from abroad.

• 4. Reading The Lungs

  ›

  In adults with normal vital signs and a normal lung examination, pneumonia is unlikely. There is no single test that cleanly separates a bacterial cause from a non-bacterial one, so the physician's overall impression turns out to be at least as reliable as formal decision rules. A chest radiograph remains a frequent tool, though lung ultrasonography has gained ground and, in expert hands, may exceed X-ray in accuracy. Ultrasound is radiation free and can be done at the bedside, but it demands real skill to run the machine and read the images.

  The stethoscope and the hands still do quiet work. Harsh breath sounds carried through inflamed lung tissue are called bronchial breathing. Crackles, also known as rales, may be heard over the affected area as the patient breathes in. Percussion of the chest may sound dull, and increased vocal resonance helps tell pneumonia apart from a pleural effusion, a pooling of fluid around the lung.

  Children are assessed by a different yardstick. The World Health Organization defines the illness clinically through cough or difficult breathing combined with a rapid respiratory rate, chest indrawing, or a falling level of consciousness. The threshold for fast breathing is more than 60 breaths per minute under two months of age, more than 50 from two months to a year, and more than 40 from one to five years. In children, low oxygen levels and lower chest indrawing prove more telling than crackles heard through a stethoscope. The presence of chest pain doubles the probability of Mycoplasma pneumoniae.

• 5. Where It Was Caught

  ›

  The setting where pneumonia takes hold shapes everything that follows: which pathogens to suspect, which antibiotics will work, and which complications to expect. Community-acquired pneumonia is picked up outside health care facilities and is less likely to involve multidrug-resistant bacteria. That advantage shrinks for anyone with recent stays in hospitals, nursing homes, or hemodialysis centers, whose risk of resistant strains climbs.

  Hospital-acquired pneumonia carries its own definition. It is pneumonia not present when a patient arrives, with symptoms that begin at least 48 hours after admission. People in hospitals often carry other illnesses that leave them more open to the pathogens around them, and the risk of multidrug-resistant organisms rises. A further category, healthcare-associated pneumonia, ties back to recent contact with the medical system through outpatient clinics, dialysis centers, chemotherapy, or home care.

  Ventilator-associated pneumonia belongs to those breathing with mechanical help. It is defined as pneumonia arising more than 48 to 72 hours after a breathing tube is placed. About 10 percent of people who need mechanical ventilation develop it. Feeding tubes carry danger too: misplacement can cause aspiration pneumonia, and 28 percent of tube malpositions end in pneumonia. One feeding tube placement system, Avanos Medical's CORTRAK 2 EAS, was recalled in May 2022 by the FDA after reported adverse events, including 60 injuries and 23 patient deaths.

• 6. Shots And Safeguards

  ›

  If preventive measures were applied worldwide, childhood deaths from pneumonia could fall by an estimated 400,000, and proper treatment everywhere could prevent another 600,000. Vaccination sits at the center of that promise. The pneumococcal vaccine has been found to lower the risk of invasive pneumococcal disease by 74 percent. Vaccinating children against Streptococcus pneumoniae has even cut infection rates in adults, because many adults catch the bacteria from children.

  The timing of vaccination recommendations keeps shifting. The CDC recommends yearly influenza vaccination for everyone 6 months and older. In October 2024 it lowered the age for adult pneumococcal vaccination from 65 to 50, reaching more people at the age when infection risk rises sharply. Strong evidence supports vaccinating children under the age of two against Streptococcus pneumoniae with the pneumococcal conjugate vaccine.

  Beyond needles, the simplest defenses matter most. Smoking appears to be the single biggest risk factor for pneumococcal pneumonia in otherwise-healthy adults, so smoking cessation ranks high, along with reducing indoor air pollution from cooking with wood, crop residues, or dung. Hand hygiene and coughing into a sleeve help, and the sick wearing surgical masks may prevent illness. In children under six months, exclusive breastfeeding lowers both the risk and the severity of disease, and zinc supplementation in children from two months to five years appears to reduce pneumonia rates.

• 7. When Treatment Begins

  ›

  For many people, antibiotics by mouth, rest, simple painkillers, and fluids are enough for a full recovery. The CURB-65 score helps decide who needs more. It assigns a point each for confusion, raised urea, a respiratory rate over 30, low blood pressure, and age 65 or older. A score of 0 or 1 usually means care at home; a 2 calls for a short stay or close follow-up; a 3 to 5 points toward hospitalization. In children, those with respiratory distress or oxygen saturation below 90 percent should be admitted.

  Antibiotic choice depends on age, underlying health, and where the infection was caught. In the UK, amoxicillin is recommended first for community-acquired pneumonia, with doxycycline or clarithromycin as alternatives. The traditional course of seven to ten days is giving way to evidence that shorter courses of three to five days work for certain types and reduce the chance of resistance. Research in children showed a 3-day course of amoxicillin matched a 7-day course. Among hospitalized patients, more than 90 percent improve on the first antibiotics tried.

  Severe illness pulls in heavier machinery and medicine. Respiratory failure that defies ordinary oxygen may demand high-flow nasal therapy, non-invasive ventilation, or a breathing tube. When sepsis brings poor blood flow, treatment starts with 30 mL per kilogram of crystalloid fluid given into a vein, with vasopressor drugs added if fluids alone fail. For viral pneumonia from influenza A or B, neuraminidase inhibitors help most when begun within 48 hours of the first symptoms.

• 8. From Hippocrates To Penicillin

  ›

  The word pneumonia comes from the Greek pneumon, meaning "lung". Hippocrates, who lived from about 460 to 370 BC, described its signs and even reported draining empyemas surgically, yet he called it a disease "named by the ancients", already old in his own time. Centuries later Maimonides, who lived from 1135 to 1204, listed the symptoms that never fail in pneumonia: acute fever, a sticking pain in the side, short rapid breaths, a serrated pulse, and cough. His description sits remarkably close to a modern textbook.

  The microbial story opened in the late 19th century. Edwin Klebs first observed bacteria in the airways of people who had died of pneumonia in 1875. Carl Friedländer and Albert Fraenkel identified the two common bacterial causes, in 1882 and 1884, and Friedländer's work introduced the Gram stain. Christian Gram's 1884 paper on that procedure helped separate the two bacteria and proved that more than one organism could cause the disease. Viral pneumonia waited until 1938, when Hobart Reimann first described it.

  The 20th century changed the odds for the first time. Before antibiotics, mortality among the hospitalized typically ran near 30 percent. Penicillin and other antibiotics, modern surgery, and intensive care drove it down sharply in the developed world. Vaccination of infants against Haemophilus influenzae type B began in 1988 and brought a steep decline soon after. The fight even has its own date: the 12th of November was declared World Pneumonia Day in 2009, a reminder that a disease the ancients named still claims millions and costs an estimated $17 billion a year worldwide.